Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric Cancer
Mark Uhlik(Tris Pharma (United States)), Laura E. Benjamin(BioHybrid Solutions (United States))
Cited by 0
Related Papers
Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A <sup>164</sup> –Driven Angiogenesis, in Part by Blocking S6Kinase
|Arteriosclerosis Thrombosis and Vascular Biology|2009|100